Chlorobenzene

Chlorobenzene

SCHEMBL5486949

C=CCl.Clc1ccccc1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.69
CYP1A2 P05177 1/20 0.48
ALDH1A1 P00352 2/20 0.43
LMNA P02545 3/20 0.41
CYP2A6 P11509 1/20 0.41
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
ORAI1 Q96D31 1/20 0.39
ORAI2 Q96SN7 1/20 0.39
ORAI3 Q9BRQ5 1/20 0.39
TRPV6 Q9H1D0 1/20 0.39
G6PD P11413 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
ATM Q13315 1/20 0.36
MAPT P10636 1/20 0.35
AKT1 P31749 1/20 0.35
IDO1 P14902 2/20 0.34
TDO2 P48775 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chlorobenzene SCHEMBL27617049 1.00 TSHR (0.69) TSHRCYP1A2ALDH1A1LMNACYP2A6
Chlorobenzene SCHEMBL4412582 0.88 TSHR (0.69) TSHRCYP1A2ALDH1A1LMNACYP2A6
Chlorobenzene SCHEMBL28269891 0.85 TSHR (0.65) TSHRCYP1A2ALDH1A1LMNACYP2A6
Chlorobenzene SCHEMBL11055239 0.85 TSHR (0.65) TSHRCYP1A2ALDH1A1LMNACYP2A6
Chlorobenzene SCHEMBL9063651 0.83
1,4-Dichlorobenzene SCHEMBL28258982 0.83 LMNA (0.61) TSHRCYP1A2ALDH1A1LMNACYP2A6
SCHEMBL24715429 0.83 TSHR (1.00) TSHRCYP1A2ALDH1A1LMNACYP2A6
Chlorobenzene SCHEMBL2168046 0.83 TSHR (1.00) TSHRCYP1A2ALDH1A1LMNACYP2A6
Chlorobenzene SCHEMBL2044 0.83
Chlorobenzene SCHEMBL1331798 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109152985-A Purifying a hydrocarbon containing predominantly C1-C5; carbon dioxide; and organic and inorganic sulfur compounds, halogenated and non-halogenated volatile organic compounds, and oxygen impurities 托普索公司 2019-01-04 CN claimed
US-20070275985-A1 Triazolopyrimidines BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2007-11-29 US disclosed
US-6395683-B1 CHEMICAL INTERMEDIATE FOR HERBICIDES; APPLYING TO PLANTS BAYER AKTIENGESELLSCHAFT (DE) 2002-05-28 US disclosed
US-5041156-A 3-aryluracils for the control of weeds CIBA-GEIGY CORPORATION (US) 1991-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275985-A1 Triazolopyrimidines DPYD, QDPR, P2RX5 TSHR 961/4885CYP1A2 36/4885ALDH1A1 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.